21 CFR Part 11 Compliance with Microsoft 365: A Practical Guide for Pharmaceutical Companies

Why This Matters to Pharmaceutical Quality and IT Teams

Digital collaboration now underpins how research, manufacturing, clinical, and quality functions operate. However, in a regulated environment, every document, approval, and data change must stand up to inspection. That is where 21 Code of Federal Regulations (CFR) Part 11 enters the scenario. It is the United States Food and Drug Administration’s (FDA) rule that sets the requirements for using electronic records and electronic signatures in activities the FDA regulates.

Many pharmaceutical organizations already use Microsoft 365 for document control, team collaboration, and workflow automation. The central question is simple: Can a Microsoft 365 environment be configured, validated, and governed so that the outcomes meet 21 CFR Part 11 compliance? The short answer is yes, when the environment is designed intentionally, validated rigorously, and operated under clear procedures. This guide shows how.

What Is 21 CFR Part 11? A Clear Definition You Can Use with Auditors

21 CFR Part 11 is an FDA regulation that defines the criteria under which the agency considers electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to systems that create, modify, maintain, archive, retrieve, or transmit electronic records that support FDA-regulated activities in pharmaceuticals, biotechnology, and medical devices.

In practice, a Part 11–compliant system must ensure:

  • Identity assurance and access control: Each user has a unique identity, authentication is enforced, and privileges are limited by role. 
  • Complete, computer-generated audit trails: Every critical event is time-stamped with the user identity and the action taken, and these trails are preserved for the required retention period. 
  • Electronic signatures that are uniquely bound to a single individual: Signatures carry the signer’s identity, date/time, and meaning (for example, approval or review) and are inseparably linked to the signed record. 
  • Validation with documented evidence: The system is proven to do what it is intended to do consistently and reproducibly through Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). 
  • Procedures, training, and governance: Written Standard Operating Procedures (SOPs), change control, periodic review, and user training keep the validated state intact.

Use that definition verbatim in kickoff meetings and audit communications; it is accurate, complete, and plain-spoken.

Can Cloud Platforms Comply with 21 CFR Part 11?

Cloud adoption raised understandable questions years ago. Today, Microsoft 365 provides enterprise-grade identity, security, auditability, records management, and integration hooks that, when configured and validated, support 21 CFR Part 11 compliance for pharmaceutical use cases. Microsoft’s independently audited service controls (for example, Service Organization Controls SOC reports, and International Organization for Standardization (ISO certifications) give a strong foundation. Your responsibility is the application layer: configuration, validation, SOPs, and ongoing governance.

Mapping 21 CFR Part 11 Requirements to Microsoft 365 Capabilities

Identity & Access Management with Azure Active Directory (Azure AD)

  • Unique user identities through Azure AD 
  • Multi-Factor Authentication (MFA) for regulated access 
  • Conditional Access to restrict sign-ins by device compliance, network location, or risk 
  • Role-based permissions via security groups mapped to functions such as Quality Assurance, Quality Control, Manufacturing, and Regulatory Affairs 
  • Sign-in and directory audit logs that record authentication and administrative events 
  • Result: Only authorized individuals can access regulated systems, and every authentication event is traceable.

Unified Audit Log & Activity Monitoring (Microsoft Purview)

  • Central Unified Audit Log that captures actions across SharePoint, OneDrive, Exchange, Teams, and Power Platform 
  • Time-stamped, user-attributed events for create, view, modify, delete, share, and administrative changes 
  • Alert policies for unusual behavior (mass deletions, permission changes, external sharing spikes) 
  • Export and retention to preserve audit evidence for the required periods 
  • Result: A computer-generated, tamper-evident audit trail, which is core to 21 CFR Part 11 compliance.

SharePoint & OneDrive Versioning, Retention, & Records Management

  • Major/minor versioning to preserve a complete document history 
  • Retention labels and policies to prevent premature deletion 
  • Records declaration so final versions become immutable records 
  • Preservation Hold Library to store prior versions automatically with metadata 
  • Result: Complete, retrievable electronic records over their full lifecycle, another Part 11 pillar.

Information Protection, Encryption, & Data Loss Prevention (DLP)

  • Encryption at rest and in transit by default 
  • Sensitivity labels to classify and protect regulated content 
  • Information Rights Management (IRM) to limit copying, printing, or forwarding 
  • DLP policies to prevent unauthorized exfiltration of sensitive data 
  • Result: Confidentiality and integrity controls that support data reliability and controlled access.

Compliant Electronic Signatures Through Trusted Integrations

  • Seamless integration with DocuSign (Life Sciences offerings), Adobe Acrobat Sign, and similar platforms 
  • Power Automate orchestration to route approvals, collect signatures, and write signature metadata back to SharePoint 
  • Signature binding that keeps signer identity, date/time, and intent tied to the exact record version 
  • Result:Electronic signatures that meet Part 11 criteria and are traceable within Microsoft 365.

Continuous Oversight with Microsoft Purview Compliance Manager

  • A 21 CFR Part 11 assessment template that maps technical controls to configuration items 
  • Scorecards and action plans for gaps 
  • Evidence tracking for audits and internal reviews 
  • Result: Ongoing visibility into your 21 CFR Part 11 compliance posture.

21 CFR Part 11 Compliance Checklist for Microsoft 365 (Pharma-Ready)

Use this as a working list for project planning, validation, and audit readiness.

1. Define Scope and Intended Use

a. List processes that create or rely on electronic records: batch release, change control, deviations/CAPA (Corrective and Preventive Action), lab data review, clinical documentation, and training records.

b. Classify systems as closed (fully controlled) or open (externally accessible) to shape controls. 

2. Establish a Computerized System Validation (CSV) Policy

a. Write how your organization will perform IQ/OQ/PQ for Microsoft 365 components, workflows, and integrated e-signature solutions.

b. Define acceptance criteria and evidence requirements.

3. Configure Azure Active Directory for Regulated Access

a. Enforce MFA, password complexity, and session timeouts. 

b. Build role-based security groups and map them to SharePoint sites, libraries, and Teams.

c. Turn on and monitor sign-in and directory audit logs.

4. Enable Unified Audit Log and Alerting

a. Confirm auditing across SharePoint, OneDrive, Teams, Exchange, and Power Platform.

b. Create alerts for sensitive events; schedule audits and log exports.

c. Preserve exported logs with retention labels for immutability.

5. Implement Versioning, Retention, and Records Declaration

a. Enable major/minor versioning on controlled libraries. 

b. Apply retention labels to regulated content; declare records when documents reach controlled states.

c. Verify the Preservation Hold Library is retaining prior versions as designed.

6. Integrate Electronic Signatures 

a. Select a trusted provider (for example, DocuSign Life Sciences or Adobe Acrobat Sign).

b. Build Power Automate flows that launch signature requests, capture signer identity and meaning, and store signed artifacts and logs in SharePoint.

c. Document the signature model in SOPs.

7. Validate (IQ/OQ/PQ) and Document Evidence

a. IQ: Prove the environment is configured as designed (for example, MFA enabled, versioning on, retention labels published).

b. OQ: Test workflows and security under normal and adverse conditions.

c. PQ: Demonstrate end-to-end performance using representative users and data.

d. Compile a Validation Summary Report.

8. Publish SOPs and Train Users

a. SOPs for user provisioning, access review, change control, document control, backup/restore, incident response, and periodic audit review.

b. Training records for administrators and business users; periodic refreshers.

9. Operate Under Governance

a. Change control for site structures, permissions, retention rules, and workflows.

b. Periodic internal audits, CAPA tracking, and management review.

Implementing Microsoft 365 for Pharmaceutical Document Control: A Practical Path

Step 1 — Discovery and Risk Assessment

Map processes, content types, and approval patterns. Identify where electronic signatures are required, what must become a record, and which steps trigger retention or review.

Step 2 — Architecture and Permissions Model

Design a least-privilege model. Separate authoring areas from controlled libraries. Use private channels or dedicated sites for regulated teams. Prevent ad-hoc sharing of controlled content.

Step 3 — Build the Approval Backbone

Create Power Automate flows for drafting, review, approval, and release. Make status visible with metadata and views. Declare records when a document is approved; route prior versions to the Preservation Hold Library automatically.

Step 4 — Wire in Electronic Signatures

Launch signature envelopes from the exact library and write the signed PDF, certificate of completion, and signature metadata back into the same controlled space. Capture signer identity, date/time, and intent in both the e-signature provider and SharePoint.

Step 5 — Validate and Go Live

Execute IQ/OQ/PQ. Fix issues with documented CAPA. Train users. Move pilot content first, then expand.

Step 6 — Monitor, Review, Improve

Review Unified Audit Logs and access reports monthly. Test alerts and recovery. Update SOPs when configurations change. Keep the validated state intact through disciplined change control.

Ready to Build a 21 CFR Part 11-Ready Microsoft 365 System?

Create controlled approvals, secure e-signatures, complete audit trails, and fully traceable records, all aligned with FDA expectations.

Get Started Today

Common Pitfalls in 21 CFR Part 11 Projects and Practical Ways to Avoid Them

  • Shared accounts: Eliminate them. Every user must have a unique identity in Azure AD. 
  • Uncontrolled collaboration: Keep draft and working discussions in Teams/SharePoint, but move controlled content to governed libraries with clear status and permissions. 
  • Missing records declaration: Approvals without records management leave gaps. Declare records and apply retention at the right status. 
  • Validation treated as a one-off: Keep test scripts, evidence, and summary reports current; re-validate when workflows or signature models change. 
  • Infrequent access reviews: Schedule quarterly reviews of group membership and elevated roles; record evidence of review.

SharePoint Online and 21 CFR Part 11: How to Make it Work in Real Life

SharePoint Online provides the backbone for pharmaceutical document control when configured for 21 CFR Part 11 compliance:

  • Library design for SOPs, work instructions, specifications, validation docs, and batch records 
  • Content types and metadata for version status, owner, effective date, and retention category 
  • Views and dashboards to show items awaiting review or approval 
  • Records declaration at Approved/Effective states 
  • Site-collection-level retention for safety-critical content 

This structure keeps collaboration agile while ensuring that controlled states are locked down and audit-ready.

Why Partner with Aufait Technologies for 21 CFR Part 11 on Microsoft 365

Translating regulation into working systems requires both GxP (Good Practice) domain fluency and Microsoft 365 engineering depth. Aufait Technologies brings both. Engagements typically include:

  • Gap analysis and roadmap using Microsoft Purview’s 21 CFR Part 11 assessment, plus Aufait checklists 
  • Tenant hardening: Azure AD MFA and Conditional Access, privileged access reviews, and directory audit readiness 
  • Document control implementation in SharePoint Online with versioning, retention, and records management 
  • Power Automate workflow design for drafting, review, approval, and release, integrated with DocuSign or Adobe Acrobat Sign 
  • Validation package: IQ/OQ/PQ protocols, executed tests, evidence repository, and Validation Summary Report 
  • SOP development and training for Quality, IT, and business teams 
  • Ongoing compliance support: periodic internal audits, change control, and inspection preparation

👉Outcome: A Microsoft 365 environment that is usable for teams, governable for Quality, and defensible during inspections.

Next Steps: Start Small, Validate Early, Scale Confidently

A focused pilot builds momentum. Choose one document family for example SOPs, design the permissions model, craft the approval workflow with e-signature, configure retention and records, and execute IQ/OQ/PQ. Train users, go live, then extend the pattern to specifications, batch records, and validation documents.

Aufait Technologies can lead that journey end-to-end: design, implementation, validation, SOPs, and readiness for inspection, so your Quality and IT teams move forward with confidence.

👉 Contact us today to book a consultation with our Microsoft experts and blueprint your digital transformation.

📢 Follow us on LinkedIn for expert insights, technology adoption tips, and compliance best practices.

Disclaimer: All the images belong to their respective owners.

Frequently Asked Questions (FAQ’s)


1. What is the full form of 21 CFR? 


21 CFR stands for Title 21 of the Code of Federal Regulations. It covers U.S. federal regulations related to food and drugs. Part 11 within Title 21 focuses on electronic records and electronic signatures.


2. What does 21 CFR Part 11 compliance mean for a pharmaceutical company?


Your electronic systems must ensure identity assurance, complete audit trails, tamper-evident records, validated performance (IQ/OQ/PQ), controlled signatures, and documented procedures and training.


3. Is Microsoft 365 suitable for 21 CFR Part 11 compliance?


Yes, when configured and validated. Azure Active Directory enables identity and access control; Microsoft Purview provides auditing and compliance assessments; SharePoint and OneDrive support versioning, retention, and records; and trusted e-signature integrations capture compliant signatures.


4. Is SharePoint Online 21 CFR Part 11 compliant? 


SharePoint Online can support Part 11 compliance when used within a validated Microsoft 365 design that includes versioning, retention, records declaration, audited workflows, and controlled e-signatures, all operated under SOPs.


5. What belongs on a 21 CFR Part 11 compliance checklist?


Unique user identities; MFA and Conditional Access; Unified Audit Log with alerts and preservation; versioning and retention; records declaration; validated e-signature process; IQ/OQ/PQ documentation; SOPs; training; periodic access and audit reviews.


6. How are electronic signatures handled in Microsoft 365?


Use integrations such as DocuSign or Adobe Acrobat Sign. Build Power Automate flows that send documents for signature, bind signer identity/date/intent to the exact approved version, and archive signed copies and certificates in SharePoint.


7. When should we re-validate?


Re-validate after meaningful changes: new approval workflows, signature model updates, retention changes, platform feature shifts affecting security or records, or remediation of audit findings.


8. Who is responsible for 21 CFR Part 11 compliance, the software provider or the pharmaceutical company?


Microsoft provides a secure, audited cloud foundation, but the regulated company remains responsible for configuring, validating, and governing the environment to meet FDA expectations. In short, Microsoft ensures the platform is trustworthy; your organization must demonstrate that its specific use of Microsoft 365 is validated and controlled.


9. Does Microsoft provide an official statement about 21 CFR Part 11 readiness?


Yes. Microsoft has published Good Practice (GxP) guidelines for Microsoft 365, confirming that the platform’s technical controls can support 21 CFR Part 11 requirements when implemented appropriately. These guidelines are available on Microsoft Learn and the Service Trust Portal, which also hosts audit reports such as Service Organization Controls (SOC 1 and SOC 2) and International Organization for Standardization (ISO) 27001 and 27018.


10. Is a standard Microsoft 365 subscription automatically compliant with FDA 21 CFR Part 11?


No. Out-of-the-box subscriptions are not automatically compliant. Compliance depends on how the tenant is configured; identity policies, retention rules, audit logging, records declaration, and validation documentation must all be aligned with your Quality Management System (QMS).


11. What role does validation play in demonstrating 21 CFR Part 11 compliance?


Validation is the documented proof that a system performs as intended. Under FDA expectations, you must execute Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). These tests verify that your Microsoft 365 configuration, including SharePoint sites, Power Automate workflows, and e-signature integration, remains consistent, reliable, and under control.


12. Can Microsoft Teams be used for regulated communication and collaboration?


Yes, but only if governed under validated procedures. Chat logs, shared files, and meeting recordings that support regulated activities should be retained and auditable. Use Microsoft Purview retention policies to preserve Teams data and include those controls in your validation scope.


13. How can a company demonstrate to the FDA that its Microsoft 365 environment is compliant? 


Auditors typically ask for: 
• The validation package (IQ/OQ/PQ reports and summary). 
• SOPs describing configuration management and access control. 
• Audit-log samples showing traceability. 
•Records management evidence, including retention labels and preservation libraries. 
• Training records for administrators and end users.
• Producing these documents and showing that procedures are followed in practice proves sustained compliance.


14. What happens if Microsoft updates its services or features? 


Cloud services evolve continuously, so each change must be evaluated through change control. Maintain a log of Microsoft feature updates relevant to your validated configuration, assess impact, perform regression testing if needed, and update your validation evidence accordingly. This preserves the system’s validated state.


15. Are third-party e-signature tools mandatory for Part 11 compliance in Microsoft 365?


Yes, if your workflows require electronic signatures with legal and regulatory standing. Integrations such as DocuSign Life Sciences or Adobe Acrobat Sign provide the required authentication, signature binding, and audit trail capabilities. Native Microsoft approvals can complement but not replace these certified solutions in GxP scenarios.


16. What is Microsoft Purview Compliance Manager, and how does it support 21 CFR Part 11 readiness?


Microsoft Purview Compliance Manager is a governance dashboard that maps regulatory requirements, such as 21 CFR Part 11, to your Microsoft 365 configuration. It provides real-time scoring, action plans, and evidence tracking. Using its built-in assessment template helps quality teams maintain continuous visibility into compliance posture.


17. Why should pharmaceutical companies involve a Microsoft partner for 21 CFR Part 11 implementation?


A certified Microsoft partner like Aufait Technologies bridges regulatory and technical expertise. Consultants understand Good Automated Manufacturing Practice (GAMP 5) principles, FDA expectations, and Microsoft’s control framework. Partner involvement accelerates validation, ensures alignment with your QMS, and reduces inspection risk.


18. Does using Microsoft 365 help with other regulatory frameworks beyond 21 CFR Part 11?


Yes. The same configuration work supports European Union Good Manufacturing Practice (EU-GMP) Annex 11, Health Insurance Portability and Accountability Act (HIPAA), and other data-integrity frameworks. Microsoft’s compliance portfolio provides cross-mapping to multiple international standards, giving your organization broader regulatory coverage.


19. What is the most common audit finding in 21 CFR Part 11 implementations?


The most frequent gaps are missing validation documentation, incomplete audit-trail reviews, and uncontrolled user access. Regulators focus on evidence that controls operate consistently, not just that they are configured once. Periodic reviews, access recertification, and training refreshers prevent these findings.


20. How can small or emerging pharma companies start their compliance journey with limited resources?


Begin with a pilot process, for example, SOP management inside Microsoft 365. Configure versioning, retention, audit logging, and an e-signature workflow; perform IQ/OQ/PQ; and document results. Expanding from a validated pilot helps demonstrate a pragmatic, risk-based approach to regulators while keeping costs predictable.

Trending Topics

Get Expert Support for 21 CFR Part 11 Compliance

Ensure your Microsoft 365 environment is validated, audit-ready, and fully aligned with FDA expectations.

Schedule a Call